These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29635466)

  • 1. Application of a Multistate Model to Evaluate Visit Burden and Patient Stability to Improve Sustainability of Human Immunodeficiency Virus Treatment in Zambia.
    Roy M; Holmes C; Sikazwe I; Savory T; Mwanza MW; Bolton Moore C; Mulenga K; Czaicki N; Glidden DV; Padian N; Geng E
    Clin Infect Dis; 2018 Sep; 67(8):1269-1277. PubMed ID: 29635466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation in adherence clubs and on-time drug pickup among HIV-infected adults in Zambia: A matched-pair cluster randomized trial.
    Roy M; Bolton-Moore C; Sikazwe I; Mukumbwa-Mwenechanya M; Efronson E; Mwamba C; Somwe P; Kalunkumya E; Lumpa M; Sharma A; Pry J; Mutale W; Ehrenkranz P; Glidden DV; Padian N; Topp S; Geng E; Holmes CB
    PLoS Med; 2020 Jul; 17(7):e1003116. PubMed ID: 32609756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Retention With 6-Month Clinic Return Intervals for Stable Human Immunodeficiency Virus-Infected Patients in Zambia.
    Mody A; Roy M; Sikombe K; Savory T; Holmes C; Bolton-Moore C; Padian N; Sikazwe I; Geng E
    Clin Infect Dis; 2018 Jan; 66(2):237-243. PubMed ID: 29020295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.
    Mody A; Eshun-Wilson I; Sikombe K; Schwartz SR; Beres LK; Simbeza S; Mukamba N; Somwe P; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
    PLoS Med; 2019 Oct; 16(10):e1002959. PubMed ID: 31661487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attrition from HIV treatment after enrollment in a differentiated service delivery model: A cohort analysis of routine care in Zambia.
    Jo Y; Jamieson L; Phiri B; Grimsrud A; Mwansa M; Shakwelele H; Haimbe P; Mukumbwa-Mwenechanya M; Mulenga PL; Nichols BE; Rosen S
    PLoS One; 2023; 18(3):e0280748. PubMed ID: 36917568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in HIV treatment differentiated care uptake during the COVID-19 pandemic in Zambia: interrupted time series analysis.
    Jo Y; Rosen S; Sy KTL; Phiri B; Huber AN; Mwansa M; Shakwelele H; Haimbe P; Mwenechanya MM; Lumano-Mulenga P; Nichols BE
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25808. PubMed ID: 34713620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to On-Time ART Drug Pick-Up and Its Association with CD4 Changes and Clinical Outcomes Amongst HIV Infected Adults on First-Line Antiretroviral Therapy in Nigerian Hospitals.
    Anoje C; Agu KA; Oladele EA; Badru T; Adedokun O; Oqua D; Khamofu H; Adebayo O; Torpey K; Chabikuli ON
    AIDS Behav; 2017 Feb; 21(2):386-392. PubMed ID: 27388161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Antiretroviral Therapy on Liver Fibrosis Among Human Immunodeficiency Virus-Infected Adults With and Without HBV Coinfection in Zambia.
    Vinikoor MJ; Sinkala E; Chilengi R; Mulenga LB; Chi BH; Zyambo Z; Hoffmann CJ; Saag MS; Davies MA; Egger M; Wandeler G;
    Clin Infect Dis; 2017 May; 64(10):1343-1349. PubMed ID: 28158504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How soon should patients be eligible for differentiated service delivery models for antiretroviral treatment? Evidence from a retrospective cohort study in Zambia.
    Jamieson L; Rosen S; Phiri B; Grimsrud A; Mwansa M; Shakwelele H; Haimbe P; Mukumbwa-Mwenechanya M; Lumano-Mulenga P; Chiboma I; Nichols BE
    BMJ Open; 2022 Dec; 12(12):e064070. PubMed ID: 36549722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya.
    Kwarisiima D; Kamya MR; Owaraganise A; Mwangwa F; Byonanebye DM; Ayieko J; Plenty A; Black D; Clark TD; Nzarubara B; Snyman K; Brown L; Bukusi E; Cohen CR; Geng EH; Charlebois ED; Ruel TD; Petersen ML; Havlir D; Jain V
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21673. PubMed ID: 28770596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitigating the effects of COVID-19 on HIV treatment and care in Lusaka, Zambia: a before-after cohort study using mixed effects regression.
    Pry JM; Sikombe K; Mody A; Iyer S; Mutale J; Vlahakis N; Savory T; Wa Mwanza M; Mweebo K; Mwila A; Mwale C; Mukumbwa-Mwenechanya M; Kerkhoff AD; Sikazwe I; Bolton Moore C; Mwamba D; Geng EH; Herce ME
    BMJ Glob Health; 2022 Jan; 7(1):. PubMed ID: 35078810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extending Visit Intervals for Clinically Stable Patients on Antiretroviral Therapy: Multicohort Analysis of HIV Programs in Southern Africa.
    Haas AD; Johnson LF; Grimsrud A; Ford N; Mugglin C; Fox MP; Euvrard J; van Lettow M; Prozesky H; Sikazwe I; Chimbetete C; Hobbins M; Kunzekwenyika C; Egger M;
    J Acquir Immune Defic Syndr; 2019 Aug; 81(4):439-447. PubMed ID: 31242142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage-sampling-based approach.
    Sikazwe I; Eshun-Wilson I; Sikombe K; Czaicki N; Somwe P; Mody A; Simbeza S; Glidden DV; Chizema E; Mulenga LB; Padian N; Duncombe CJ; Bolton-Moore C; Beres LK; Holmes CB; Geng E
    PLoS Med; 2019 May; 16(5):e1002811. PubMed ID: 31150380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Care Cascade Outcomes Among People Eligible for Antiretroviral Therapy Who Are Newly Linking to Care in Zambia: A Multistate Analysis.
    Mody A; Glidden DV; Eshun-Wilson I; Sikombe K; Simbeza S; Mukamba N; Somwe P; Beres LK; Pry J; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
    Clin Infect Dis; 2020 Dec; 71(10):e561-e570. PubMed ID: 32173743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Viral Suppression With Streamlined Care in the SEARCH Study.
    Hickey MD; Ayieko J; Kwarisiima D; Opel FJ; Owaraganise A; Balzer LB; Chamie G; Jain V; Peng J; Camlin C; Charlebois ED; Cohen CR; Bukusi EA; Kamya MR; Petersen ML; Havlir DV
    J Acquir Immune Defic Syndr; 2020 Dec; 85(5):571-578. PubMed ID: 32991337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study.
    Scott CA; Iyer HS; McCoy K; Moyo C; Long L; Larson BA; Rosen S
    BMC Public Health; 2014 Mar; 14():296. PubMed ID: 24684772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disengagement from care in a decentralised primary health care antiretroviral treatment programme: cohort study in rural South Africa.
    Mutevedzi PC; Lessells RJ; Newell ML
    Trop Med Int Health; 2013 Aug; 18(8):934-41. PubMed ID: 23731253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors before enrolment are associated with being removed from a Pharmacy-only Refill Programme at a large urban HIV/AIDS clinic, Uganda.
    Nakiwogga-Muwanga A; Katabira E; Kiragga A; Kambugu A; Nakibuuka-Lubwama E; Manabe YC; Alamo ST; Colebunders R
    Int J STD AIDS; 2014 Feb; 25(2):105-12. PubMed ID: 23970633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported Reasons for Stopping Care or Switching Clinics in Zambia: A Multisite, Regionally Representative Estimate Using a Multistage Sampling-based Approach in Zambia.
    Sikazwe I; Eshun-Wilson I; Sikombe K; Beres LK; Somwe P; Mody A; Simbeza S; Bukankala C; Glidden DV; Mulenga LB; Padian N; Ehrenkranz P; Bolton-Moore C; Holmes CB; Geng EH
    Clin Infect Dis; 2021 Oct; 73(7):e2294-e2302. PubMed ID: 33011803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.